Volume 17, Issue 5 p. 847-855
FEATURED ARTICLE

Utility of MRI in the identification of hippocampal sclerosis of aging

Davis C. Woodworth

Davis C. Woodworth

Department of Neurology, University of California, Orange, California, USA

Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, California, USA

Search for more papers by this author
Hannah L. Nguyen

Hannah L. Nguyen

Department of Biological Sciences, University of California, Irvine, California, USA

Search for more papers by this author
Zainab Khan

Zainab Khan

Department of Biological Sciences, University of California, Irvine, California, USA

Search for more papers by this author
Claudia H. Kawas

Claudia H. Kawas

Department of Neurology, University of California, Orange, California, USA

Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, California, USA

Department of Neurobiology and Behavior, University of California, Irvine, California, USA

Search for more papers by this author
María M. Corrada

María M. Corrada

Department of Neurology, University of California, Orange, California, USA

Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, California, USA

Department of Neurobiology and Behavior, University of California, Irvine, California, USA

Department of Epidemiology, University of California, Irvine, California, USA

Search for more papers by this author
S. Ahmad Sajjadi

Corresponding Author

S. Ahmad Sajjadi

Department of Neurology, University of California, Orange, California, USA

Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, California, USA

Correspondence

S. Ahmad Sajjadi, Office 364, Med Surge II, Academy Way, Irvine, CA, 92697, USA.

E-mail: [email protected]

Search for more papers by this author
First published: 07 December 2020
Citations: 9

Abstract

Introduction

Hippocampal sclerosis of aging (HS) is a common pathology often misdiagnosed as Alzheimer's disease. We tested the hypothesis that participants with HS would have a magnetic resonance imaging (MRI)-detectable hippocampal pattern of atrophy distinct from participants without HS, both with and without Alzheimer's disease neuropathology (ADNP).

Methods

Query of the National Alzheimer's Coordinating Center database identified 198 participants with MRI and autopsy. Hippocampal subfields were segmented with FreeSurfer v6. Analysis of covariance for subfield volumes compared HS+ participants to those without HS, both with ADNP (HS–/ADNP+) and without (HS–/ADNP–).

Results

HS+ participants (N = 27, 14%) showed atrophied cornu ammonis 1 (CA1; left P < .001, ηp= 0.14; right P = .001, ηp= 0.09) and subiculum (left P < .001, ηp= 0.139; right P = .001, ηp= 0.085) compared to HS–/ADNP+ (N = 100, 51%). Compared to HS–/ADNP– (N = 71, 36%), HS+ also had atrophy in subiculum (left P < .001, ηp= 0.235; right P = .002, ηp= 0.137) and CA1 (left P < .001, ηp= 0.137; right P = .006, ηp= 0.070).

Discussion

Subiculum and CA1 atrophy from clinical MRI may be a promising in vivo biomarker for HS.